considerations for the clinical impact of next-generation imaging in prostate cancer
Published 4 years ago • 342 plays • Length 10:35Download video MP4
Download video MP3
Similar videos
-
7:40
koo - next generation imaging for prostate cancer
-
20:46
next generation imaging in prostate cancer - pylarify
-
26:54
fluciclovine (18f) pet/ct impact on clinical management of recurrent prostate cancer
-
14:39
just the beginning: what's next for radiotheranostics in prostate cancer?
-
10:26
next generation imaging for localization of recurrent prostate cancer
-
6:18
updates of changes in the early detection of prostate cancer nccn guidelines 2021
-
20:50
active surveillance 2021 - from bench to bedside
-
56:52
pelvic mass management
-
48:12
considerations to improve screening for prostate cancer
-
21:44
how to utilize mri for focal therapy planning
-
1:34
dr. koo on the need for next-generation imaging in prostate cancer
-
20:48
mri in the enhanced detection of prostate cancer: what urologists need to know
-
10:51
advanced prostate cancer clinical trials update 2022
-
31:23
clinical case - staging of high-risk pca
-
21:20
next generation sequencing of prostate tumors: use of individualized biomarkers
-
12:17
psma pet imaging in advanced prostate cancer
-
30:34
expanding the role of surgical management of high risk prostate cancer
-
36:59
lessons learned from the clinical translation of a new imaging agent for prostate cancer
-
17:12
practical applications & clinical utility of pet agent pylarify (piflufolastat f 18) injection